Selma Blair reveals multiple sclerosis diagnosis
Actress Selma Blair's revelation that she has multiple sclerosis is being met by an outpouring of support. The 46-year-old star disclosed her diagnosis in an emotional Instagram post. The post is bringing new attention to MS. Dr. Tara Narula reports on the symptoms and treatments. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 22, 2018 Category: Consumer Health News Source Type: news

Actress Selma Blair reveals multiple sclerosis diagnosis
"Cruel Intentions" star writes, "I am in the thick of it but I hope to give some hope to others. And even to myself" (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 22, 2018 Category: Consumer Health News Source Type: news

Selma Blair MS: What is multiple sclerosis? Signs and symptoms to look out for
SELMA Blair MS: The actress has revealed she has been diagnosed with multiple sclerosis. But what is MS and what are the signs and symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - October 21, 2018 Category: Consumer Health News Source Type: news

A Newly Appreciated Aspect of Multiple Sclerosis A Newly Appreciated Aspect of Multiple Sclerosis
Drs Stephen Krieger and James Sumowski discuss developments in understanding and managing the cognitive deficits associated with MS.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 19, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news

Safe to Stop MS Disease-Modifying Therapy After Age 60? Safe to Stop MS Disease-Modifying Therapy After Age 60?
To add more evidence to the controversial debate over stopping immunomodulatory therapy for multiple sclerosis after age 60, researchers focus on quality of life, walking performance, and relapse rates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 19, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Novel Anti-B-Cell Therapy Looks Promising in MS Novel Anti-B-Cell Therapy Looks Promising in MS
A new and novel oral therapy for multiple sclerosis, which inactivates rather than depletes B cells, has shown promising results in its first efficacy study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 18, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Yale-led team finds missing-in-action MS genes
Researchers have found four new genes that act independently as risk factors for the disabling autoimmune disorder multiple sclerosis. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 18, 2018 Category: Universities & Medical Training Source Type: news

Medical News Today: MS: Gut bacteria may trigger harmful mechanism
While the cause of multiple sclerosis remains unknown, new research suggests that the harmful autoimmune response associated with it originates in the gut. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 18, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Cannabinoids Mildly Effective for Multiple Sclerosis Symptoms Cannabinoids Mildly Effective for Multiple Sclerosis Symptoms
Many patients with MS try cannabis products to alleviate symptoms of pain, spasticity, and bladder dysfunction. A large meta-analysis suggests that these agents are mildly efficacious.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 17, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Researchers propose conceptual framework to study role of exercise in multiple sclerosis
(Kessler Foundation) 'Exercise is a low-cost, non-invasive modality,' noted Dr. John DeLuca, 'so we are very interested in learning more about how activity results in these improvements. Rethinking how we view exercise in the long-term management of MS and other neurological conditions is our first step. We anticipate that the PRIMERS framework will accelerate advances in treatment by integrating the contributions from neuroscience, neurophysiology, and neurorehabilitation. " (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 17, 2018 Category: International Medicine & Public Health Source Type: news

FDA needs best and brightest to advance a new era of medicine with America ’s biopharmaceutical companies
The U.S Food and Drug Administration (FDA) plays a critical role in protecting and promoting the health of all Americans. Every day, the FDA does important work to ensure the safety, efficacy and security of our nation ’s medical products, including human drugs and biologics. From reviewing the drug profile of a first-in-class medicine up for approval, to inspecting a medicine’s manufacturing site, the FDA’s experts engage in a range of regulatory review activities intended to bring safe and effective new me dicines to patients in a timely manner. In the past year alone, the FDA approved a record number o...
Source: The Catalyst - October 16, 2018 Category: Pharmaceuticals Authors: Richard Moscicki, M.D. Tags: FDA PDUFA Source Type: news

Environmental factors may trigger onset of multiple sclerosis
(American Friends of Tel Aviv University) A new Tel Aviv University study finds that certain environmental conditions like salt concentrations and temperature may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis (MS). Myelin sheaths are the 'insulating tape' surrounding axons; axons carry electrical impulses in neurons. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2018 Category: International Medicine & Public Health Source Type: news

Appeals court upholds canceled patent for blockbuster MS drug
On Friday, an appeals court upheld an earlier ruling that canceled patents for a blockbuster multiple sclerosis drug owned by Teva Pharmaceuticals. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 15, 2018 Category: Pharmaceuticals Source Type: news

iPad 9-Hole Peg Test Correlates With MS Imaging iPad 9-Hole Peg Test Correlates With MS Imaging
Testing manual dexterity over time using tablet-based technology could streamline the clinical monitoring of people with multiple sclerosis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Cannabinoids Mildly Effective for Treating MS Symptoms in Adults
MONDAY, Oct. 15, 2018 -- Cannabinoids may be mildly effective at treating spasticity, pain, and bladder dysfunction in adults with multiple sclerosis (MS), according to a review published online Oct. 12 in JAMA Network Open. Mari Carmen... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 15, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: Do cannabinoids ease multiple sclerosis symptoms?
Uncovering whether cannabinoids can relieve the symptoms of multiple sclerosis is proving challenging. A new meta-analysis takes a look at the data. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 14, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

' Burning Debate' on McDonald Diagnostic Criteria in MS'Burning Debate' on McDonald Diagnostic Criteria in MS
New McDonald diagnostic criteria for multiple sclerosis were the focus of a debate here at the ECTRIMS 2018 congress that spilled over onto Twitter.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 12, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

U.S. appeals court upholds ruling that canceled Teva Copaxone patents
A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone. (Source: Reuters: Health)
Source: Reuters: Health - October 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

New, Non-Invasive, Visual-Field Testing Device
FDA-cleared objective device, objectiveFIELD, tests both eyes open simultaneously in a non-contact manner. objectiveFIELD is easy to administer and takes a few minutes to complete different examinations including normal, glaucoma, macular degeneration, diabetic retinopathy, multiple sclerosis, epilepsy, migraine, concussion, and other neuro-vision conditions. This story is related to the following:Medical Devices (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 12, 2018 Category: Medical Devices Source Type: news

Medical Marijuana Might Help MS Patients, But Uncertainty Remains
FRIDAY, Oct. 12, 2018 -- Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients. Drugs containing the major chemical compounds in cannabis are associated with a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 12, 2018 Category: General Medicine Source Type: news

Medical marijuana for symptoms in patients with multiple sclerosis
This study analyzed 17 clinical trials including 3,161 patients to evaluate medicinal cannabinoids -- the chemical compounds in cannabis -- for the treatment of symptoms in patients with   multiple sclerosis (MS). Cannabinoids were associated with a limited and mild reduction in the subjective patient assessment of spasticity (contracted muscles), pain and bladder dysfunction in this systematic review and meta-analysis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 12, 2018 Category: International Medicine & Public Health Source Type: news

Pregnancy Rates Increasing in Women With Multiple Sclerosis Pregnancy Rates Increasing in Women With Multiple Sclerosis
Pregnancy rates in women with MS are increasing, confirming the well-established'down-up trend'for reduced relapse risk during pregnancy and the abrupt increase in relapse risk after delivery, new research shows.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - October 11, 2018 Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news

Making it work: experience of living with a person who falls due to multiple sclerosis - Carling A, Nilsag ård Y, Forsberg A.
PURPOSE: The purpose of this study was to describe how everyday life is experienced by next of kin sharing residence with a person who falls due to multiple sclerosis (MS). METHODS: Twenty face-to-face interviews were analysed using a qualitative c... (Source: SafetyLit)
Source: SafetyLit - October 11, 2018 Category: International Medicine & Public Health Tags: Falls Source Type: news

Treadmill Walking Speeds Up Cognition in MS Treadmill Walking Speeds Up Cognition in MS
A new study found that treadmill walking produced a statistically and clinically significant improvement in cognition in patients with multiple sclerosis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Link between gut flora and multiple sclerosis discovered
(University of Zurich) In multiple sclerosis, a defective response of the body's own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than previously assumed, researchers at the University of Zurich have now found. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 11, 2018 Category: Infectious Diseases Source Type: news

Familial MS May Have a More Aggressive Course Familial MS May Have a More Aggressive Course
Familial multiple sclerosis, defined as having a first-, second-, or third-degree relative with the disease, may have a more aggressive course than sporadic cases, new data suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Up to 10-years of follow-up data reaffirm safety profile of Mavenclad (cladribine tablets)
Merck, the vibrant science and technology company, today announced the presentation of new data for MAVENCLAD® (cladribine tablets) at the 34th Congress of the European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS) in Berlin, Germany. (Source: World Pharma News)
Source: World Pharma News - October 10, 2018 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news

OCREVUS (ocrelizumab) data show early initiation of treatment reduces disability progression over five years in relapsing and primary progressive multiple sclerosis
Roche announced today that new OCREVUS ® (ocrelizumab) data will be presented at the 34th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) from 10 October to 12 October in Berlin, Germany. (Source: Roche Media News)
Source: Roche Media News - October 10, 2018 Category: Pharmaceuticals Source Type: news

OCREVUS (ocrelizumab) data show early initiation of treatment reduces disability progression over five years in relapsing and primary progressive multiple sclerosis
Roche announced today that new OCREVUS ® (ocrelizumab) data will be presented at the 34th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) from 10 October to 12 October in Berlin, Germany. (Source: Roche Investor Update)
Source: Roche Investor Update - October 10, 2018 Category: Pharmaceuticals Source Type: news

Remote monitoring boost for long-term patients
Patients with long-term medical conditions, such as depression, multiple sclerosis and epilepsy, need regular monitoring, but having to visit the clinic frequently for tests can be a problem. An EU- and industry-funded project is aiming to implement real-time, on-demand monitoring through remote assessment, to potentially improve patient experience and outcomes and increase clinical efficiency. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - October 9, 2018 Category: Research Source Type: news

Novartis Announces FDA and EMA Filing Acceptance of Siponimod for Secondary Progressive Multiple Sclerosis (SPMS)
Basel, October 08, 2018 - Novartis today announced that both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company's New Drug Application (NDA) and Marketing Authorization Application (MAA)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 8, 2018 Category: Drugs & Pharmacology Source Type: news

Pregnancy Rates Rise Among Women with Multiple Sclerosis
(MedPage Today) -- But most MS patients stop treatment a year before conceiving (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - October 2, 2018 Category: Neurology Source Type: news

Roche to present five-year OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive multiple sclerosis (MS) at ECTRIMS
Roche announced today that new data on OCREVUS ® (ocrelizumab) in people with relapsing and primary progressive forms of MS will be presented during the 34th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Berlin, Germany, 10 to 12 October. (Source: Roche Media News)
Source: Roche Media News - October 2, 2018 Category: Pharmaceuticals Source Type: news

Roche to present five-year OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive multiple sclerosis (MS) at ECTRIMS
Roche announced today that new data on OCREVUS ® (ocrelizumab) in people with relapsing and primary progressive forms of MS will be presented during the 34th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Berlin, Germany, 10 to 12 October. (Source: Roche Investor Update)
Source: Roche Investor Update - October 2, 2018 Category: Pharmaceuticals Source Type: news

Smokers are more likely to develop multiple sclerosis and become disabled by the condition
The London-based charity The MS Society found that quitting smoking could delay the onset of untreatable secondary progressive MS by as much as eight years but most people are unaware. (Source: the Mail online | Health)
Source: the Mail online | Health - September 24, 2018 Category: Consumer Health News Source Type: news

Multiple Sclerosis: What are astrocytes? Cell now KEY to brain inflammation
MULTIPLE Sclerosis is a devastating neurological disease, which comes with a host of debilitating symptoms and can ruin people ’s chances at a good quality of life. A new study has confirmed the presence of a specific cell which could change the way the disease is treated. (Source: Daily Express - Health)
Source: Daily Express - Health - September 21, 2018 Category: Consumer Health News Source Type: news

Medical News Today: What are the early signs of MS?
The early signs and symptoms of MS can vary widely, and some can be significantly challenging or debilitating. Here, learn more about the early symptoms of MS, such as vision problems and numbness, and when to consult a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 20, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

MS researchers find well-being differs with age in multiple sclerosis
(Kessler Foundation) The oldest group reported the lowest levels of depressive symptoms and the highest levels of Physical QOL. 'These results were unexpected,' said Dr. Strober, 'given the functional limitations, disease progression, and neurological lesions seen in the aging MS population. Contrary to our hypothesis, the trend by age paralleled the general population. Younger individuals with MS are at greater risk for depression and poor QOL. If confirmed, targeted screening for depression by age may be warranted in this population.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 19, 2018 Category: International Medicine & Public Health Source Type: news

Blocking brain messages in lymphatic vessels may slow MS
Blocking messages in lymphatic vessels from the brain to the immune system shows promise as a potential way to treat multiple sclerosis, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 18, 2018 Category: Consumer Health News Source Type: news

Medical News Today: MS: Is a 'rogue' brain and lymph node interaction to blame?
New research suggests that the brain sends a 'rogue' signal to the immune system through lymphatic vessels, thus triggering multiple sclerosis mechanisms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 18, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Kessler researchers show Speed of Processing Training effective in multiple sclerosis
(Kessler Foundation) 'These results indicate that processing speed is fundamental to higher order cognitive function in individuals with MS,' said Dr. Chiaravalloti, the Foundation's director of Neuropsychology, Neuroscience, and Traumatic Brain Injury Research. 'Looking at the impact of cognitive interventions on neuropsychological measures isn't enough, however. The outcomes of our research studies need to include the effects of cognitive rehabilitation protocols on how people perform in their daily lives.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2018 Category: International Medicine & Public Health Source Type: news

Beyond the Room Edinburgh Colloquium 2018 Podcasts
For the first time at a Cochrane Colloquium, we will be taking the conversation  #BeyondTheRoom. Beyond the Room is a digital conference service, started in 2016 by Andr é Tomlin from the Mental Elf. Its aim is to  increase the reach and impact of health events by live tweeting and podcasting from them, to involve people virtually and facilitate a much more democratic conversation. Our Beyond the Room team includes  @SarahChapman30@TheJackLeahy@Mental_Elf@MightyCasey@DBadenoch@sally_crowe Selena@CochraneUK and  @Laconic_doc They have recorded podcasts with some of the speakers and prese...
Source: Cochrane News and Events - September 17, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

UVA identifies brain's lymphatic vessels as new avenue to treat multiple sclerosis
(University of Virginia Health System) The vessels appear to carry previously unknown messages from the brain to the immune system that ultimately cause the disease symptoms. Blocking those messages may offer doctors a new way to treat a potentially devastating condition that affects more than 2 million people. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 17, 2018 Category: Infectious Diseases Source Type: news

Patient Engagement – Careful What You Wish For
I’m often asked about my take on patient engagement. These buzzwords are losing their meaning. Frankly, I find myself at a loss to answer, even though I say patient engagement is my passion. Engagement from whose point of view? A person engaged in their own health – Isn’t everyone engaged in their own health? My symptoms affect me. I’m in pain. I can’t function as I’d like to. I’m sad. I’m anxious. I react. I manage or I don’t. I can accept, deny, adapt. I suffer, I advocate, I overcome. Maybe it’s my parent’s health or my partner’s or my child’...
Source: Society for Participatory Medicine - September 16, 2018 Category: General Medicine Authors: Danny van Leeuwen Tags: General empowered patient participatory medicine Patient engagement Patient Participation Source Type: news

Medical News Today: Brain cell identified as 'mediator of disease'
The findings could help us devise new treatments for a range of diseases that affect the central nervous system, such as multiple sclerosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 15, 2018 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news

PARADIGMS: Fingolimod Effective, Well Tolerated in Children PARADIGMS: Fingolimod Effective, Well Tolerated in Children
Results show an 82% reduced annualized relapse rate among pediatric patients with multiple sclerosis taking fingolimod compared with those taking interferon-beta1a.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Threshold-based fall detection using the hybrid of tri-axial accelerometer and gyroscope - Wang FT, Chan HL, Hsu MH, Lin CK, Chao PK, Chang YJ.
OBJECTIVE: Falling is an important health maintenance issue for the elderly and people with movement disorders, strokes and multiple sclerosis. With the development of light, low-cost wearable technology, inertia-based fall detection has gained much attent... (Source: SafetyLit)
Source: SafetyLit - September 14, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Research in yeast leads to serendipitous finding about a central nervous system disorder
(Salk Institute) Researchers from the Salk Institute found that an important quality control mechanism in baker's yeast is closely connected to hypomyelinating leukodystrophy, a debilitating disease found in children. The findings could indicate a therapeutic approach for this rare disease, as well as for multiple sclerosis and other neurodegenerative diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2018 Category: International Medicine & Public Health Source Type: news

Kessler Foundation joins international study to improve cognitive dysfunction in MS
(Kessler Foundation) Nancy Chiaravalloti, PhD, and John DeLuca, PhD, have been awarded a $410,000 grant from the Multiple Sclerosis (MS) Society of Canada and the MS Scientific Research Foundation to assess the efficacy of a mixed-method intervention to improve cognition in people with progressive MS. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2018 Category: International Medicine & Public Health Source Type: news

Fingolimod Cuts Multiple Sclerosis Relapses in Pediatric Patients
WEDNESDAY, Sept. 12, 2018 -- Among pediatric patients with relapsing multiple sclerosis, fingolimod is associated with a lower rate of relapse but a higher rate of serious adverse events than interferon beta-1a, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 12, 2018 Category: Pharmaceuticals Source Type: news